Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
News: $CO Global Cord Blood Corporation Announces Receipt of Preliminary Non-Binding Proposal to Acquire the Company
HONG KONG , June 4, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that its board of directors has re...
Read the whole news https://marketwirenews.com/news-releases/global-cord-blood-corporation-announces-receipt-of-preliminary-non-binding-proposal-to-acquire-the-company-8296348.html
Closed over the fifty day moving average on volume!!!!, 0.0307
This is just the beginning friends! Should be Northbound again tomorrow!!!! $USRM$$$$$
failure to deliver error's today on china blood corp. Market Makers been selling phantom shares?
CO should accept the buyout. Maybe they know another offer is coming since their the only allowed blood depository in there state.
$CO recent news/filings
bullish
## source: finance.yahoo.com
Mon, 20 Apr 2015 04:01:00 GMT ~ The North Face Aims to Recycle More Than 100,000 lbs of Apparel and Footwear in 2015
[Business Wire] - The North Face today announced the expansion of its Clothes The Loop recycling program to all of its retail and outlet stores in the U.S. in tandem with an in-store and social media campaign to encourage consumers to recycle unwanted apparel and footwear from any brand in any condition.
read full: http://finance.yahoo.com/news/north-face-aims-recycle-more-040100732.html
*********************************************************
Tue, 24 Mar 2015 13:25:01 GMT ~ China Cord Blood (CO) Worth Watching: Stock Gains 7.3% - Tale of the Tape
read full: http://finance.yahoo.com/news/china-cord-blood-co-worth-132501739.html
*********************************************************
Thu, 19 Mar 2015 16:24:00 GMT ~ An Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital
[PR Newswire] - NEW YORK, March 19, 2015 /PRNewswire/ -- The following is an open letter sent March 19, 2015 to the Board of Directors of China Cord Blood Corp (NYSE: CO) from Jayhawk Capital. As a substantial and long ...
read full: http://finance.yahoo.com/news/open-letter-board-china-cord-162400454.html
*********************************************************
Thu, 26 Feb 2015 13:00:00 GMT ~ China Cord Blood Corp Earnings Call scheduled for 8:00 am ET today
read full: http://biz.yahoo.com/cc/4/148164.html
*********************************************************
Wed, 25 Feb 2015 22:25:03 GMT ~ China Cord Blood posts 3Q profit
read full: http://sg.finance.yahoo.com/news/china-cord-blood-posts-3q-222503904.html
*********************************************************
$CO charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$CO company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/CO/company-info
Ticker: $CO
OTC Market Place: Not Available
CIK code: 0001467808
Company name: China Cord Blood Corp.
Incorporated In: DE, USA
Business Description:
$CO share structure
## source: otcmarkets.com
Market Value: $472,331,015 a/o Apr 21, 2015
Shares Outstanding: 73,003,248 a/o Mar 31, 2013
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.0001
$CO extra dd links
Company name: China Cord Blood Corp.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/CO/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/CO/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=CO+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=CO+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=CO+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/CO/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/CO/news - http://finance.yahoo.com/q/h?s=CO+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/CO/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/CO/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/CO/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/CO/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/CO/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/CO/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/CO/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/CO/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=CO+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/CO
DTCC (dtcc.com): http://search2.dtcc.com/?q=China+Cord+Blood+Corp.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=China+Cord+Blood+Corp.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=China+Cord+Blood+Corp.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/CO/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/CO
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/CO/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/CO/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/CO/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001467808&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/CO/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/CO/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/CO/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/CO/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=CO&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=CO
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/CO/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=CO+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=CO+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=CO
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=CO
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=CO+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/CO/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=CO+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/CO.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=CO
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/CO/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/CO/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/CO/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/CO/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/CO
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/CO
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/CO:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=CO
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=CO
$CO DD Notes ~ http://www.ddnotesmaker.com/CO
This http://www.answers.com/Q/How_many_babies_are_born_every_day_in_China combined with the cost of collection and monthly charge for storage as the #1 business of its kind = $$$.
$CO DD Notes ~ http://www.ddnotesmaker.com/CO
bullish
$CO recent news/filings
## source: finance.yahoo.com
Tue, 26 Aug 2014 11:38:05 GMT ~ Strength Seen in China Cord Blood (CO): Stock Soars 19.5%
read full: http://finance.yahoo.com/news/strength-seen-china-cord-blood-113805091.html
*********************************************************
Mon, 25 Aug 2014 11:01:00 GMT ~ 7:01 am China Cord Blood receives notice of transaction regarding its 7% senior convertible note due 2017 held by Golden Meditech
read full: http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#co
*********************************************************
Mon, 25 Aug 2014 11:00:00 GMT ~ China Cord Blood Corporation Receives Notice of Transaction Regarding its 7% Senior Convertible Note Due 2017 Held by Golden Meditech
[PR Newswire] - HONG KONG, Aug. 25, 2014 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic ...
read full: http://finance.yahoo.com/news/china-cord-blood-corporation-receives-110000105.html
*********************************************************
Thu, 21 Aug 2014 11:00:00 GMT ~ China Cord Blood Corporation to Report First Quarter of Fiscal 2015 Financial Results
[PR Newswire] - HONG KONG, Aug. 21, 2014 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced its plan to release financial results for the first quarter of fiscal year 2015 ...
read full: http://finance.yahoo.com/news/china-cord-blood-corporation-report-110000501.html
*********************************************************
Sat, 09 Aug 2014 17:04:05 GMT ~ CHINA CORD BLOOD CORP Financials
read full: http://finance.yahoo.com/q/is?s=co&annual
*********************************************************
$CO charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$CO company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/CO/company-info
Ticker: $CO
OTC Market Place: Not Available
CIK code: 0001467808
Company name: China Cord Blood Corp.
Incorporated In: DE, USA
Business Description:
$CO share structure
## source: otcmarkets.com
Market Value: $339,465,103 a/o Aug 25, 2014
Shares Outstanding: 73,003,248 a/o Mar 31, 2013
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.0001
$CO extra dd links
Company name: China Cord Blood Corp.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/CO/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/CO/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=CO+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=CO+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=CO+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/CO/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/CO/news - http://finance.yahoo.com/q/h?s=CO+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/CO/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/CO/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/CO/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/CO/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/CO/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/CO/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/CO/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/CO/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=CO+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/CO
DTCC (dtcc.com): http://search2.dtcc.com/?q=China+Cord+Blood+Corp.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=China+Cord+Blood+Corp.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=China+Cord+Blood+Corp.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/CO/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/CO
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/CO/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/CO/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/CO/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001467808&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/CO/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/CO/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/CO/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/CO/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=CO&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=CO
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/CO/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=CO+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=CO+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=CO
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=CO
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=CO+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/CO/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=CO+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/CO.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=CO
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/CO/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/CO/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/CO/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/CO/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/CO
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/CO
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/CO:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=CO
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=CO
$CO DD Notes ~ http://www.ddnotesmaker.com/CO
Anyone watching this one? Could get interesting with earnings out tomorrow
Look at the 6m and one year chart.....lol that my friend will speak for itself and give you the trueful answer in which you seek.... _A_ ? ahahahaha
Umatunaaaaaaa -0
http://www.daru.org.au/organisation/disability-discrimination-legal-service
Hahahahaaaaa..... NOPE NOT EVEN CLOSE.... SOLD GREEN A COUPLE OF WEEKS AGO...... AHAHAHAHA NICE TRY _A_? MARKET WAS A DOWN DAY BUT THIS WENT UP A? BUT NO POS AT THIS TIME
UMATUNAAAAAA -0
HAVE A GREAT DAY!!!! _A_?
Losing money here too ....A?
They are being very misleading on their website too. A lot of red flags.
Good luck with it and I hope you end up with a good trade. ;)
I agree.... the kicker is no way to verify Chinese company filings.... I don't care for that part... the company is doing excellent on paper but it's just paper... I just want to see 4's then I look for and exit point.
THANKS FOR YOUR REPLY!
I sold mine off a long time ago. I don't trust the company.
Add the fact that Golden Meditech Holdings Limited has been gradually taking a larger stake in the company. I envision them going private with a delisting.
Following quote from:
http://1.usa.gov/13SUrri
"Golden Meditech beneficially owns an aggregate of 48,299,307 Ordinary Shares, representing approximately 53.3% of the total issued and outstanding Ordinary Shares based on 73,003,248 Ordinary Shares outstanding as of March 31, 2013"
**********
Mr. Yuen Kam, the Chairman and CEO of Golden Meditech is now the Chairman and Director of China Cord Blood.
http://bit.ly/13SUrrk
He's already hiding things from US investors. See: http://1.usa.gov/13SUtiT
There's no way to verify Chinese company filings. The risk is to high. I may be wrong, but, I won't touch it.
In Reply to 'Trader Joey'
Well seems like the tide is changing as of late.... so many old posts here I'm wondering if people have started buying again? Insider buying 366,782 shares on Tuesday along with upgrades.... I still like this CO its time to quit trading sideways.. LOL
Well seems like the tide is changing as of late.... so many old posts here I'm wondering if people have started buying again? Insider buying 366,782 shares on Tuesday along with upgrades.... I still like this CO its time to quit trading sideways.. LOL
No real posts on this stock for a long time..... it's been trading sideway for a very very long time..... the last few weeks it has been coming alive...woo hoo.... great lil company, I just don't understand lack of interest.... now I see vol spikes and insider buying by KENT C MCCARTHY on July 9th 2013.....366,782 shares.
SA article was great last week on the 5th and now The Street has upgraded CO to a buy today....
More upside is happening!!
ECHO ECHO anyone out there?
~ $CO ~ Daily Par Sar Buy Signal ~ Criteria alert triggered during a recent trading session!
$CO has just triggered the "Parabolic SAR Buy Signals" scan criteria at Stockcharts.com
~ http://tinyurl.com/SAR-BUY ~
For a more in Depth study and DD profile, similar to the one contained in this link: ~ http://tinyurl.com/DDexample ~
Click the following link and type ticker or brief message asking me about the DD: ~ http://tinyurl.com/GET-THE-DD ~
What does the scan "Parabolic SAR Buy Signals" mean? Below is an image example and study link.
~ http://stockcharts.com/school/doku.php?id=chart_school:technical_indicators:parabolic_sar ~
To find other similar posts of "CO" utilize the links that follow.
Search MACDgyver's "Parabolic SAR Buy Signals" posts: ~ http://investorshub.advfn.com/boards/msgsearchbymember.aspx?searchID=251916&srchyr=2013&SearchStr=ParSarBuyScan ~
Search MACDgyver's posts for symbol "CO": ~ http://investorshub.advfn.com/boards/msgsearchbymember.aspx?searchID=251916&srchyr=2013&SearchStr=CO ~
Search Ihub for "CO" posts: ~ http://investorshub.advfn.com/boards/msgsearch.aspx?SearchStr=CO ~
For more in depth training and information visit Chartschool on the Stockcharts page.
~ http://stockcharts.com/school/doku.php?id=chart_school ~
Also don't forget the Ihub Edu Channel.
~ http://investorshub.advfn.com/boards/education.aspx ~
c
are they going to buy cbai asets on the cheap
China Cord Blood and Golden Meditech Holdings Limited enter into convertible note financing to further expand cord blood banking services; Mr. Yuen Kam will be appointed as Chairman (CO) 2.67 : Co and Golden Meditech Holdings, an integrated healthcare enterprise in China, announced that they entered into agreements under which Golden Meditech is expected to invest $50 million into CCBC to support its further business expansion and to capitalize on China's fast-growing healthcare services industry. The convertible note carries a 7% interest per annum and a total rate of return of 12% per annum. The convertible note holder can convert the convertible note into ordinary shares of the Company at a conversion price of $2.838. The total ordinary shares issuable represents approximately 15.5% of the enlarged share capital of the Company. Upon completion of the transaction, Mr. Yuen Kam, will be appointed as Chairman of CCBC and Ms. Ting Zheng will continue her role as the Chief Executive Officer of CCBC. Mr. Yuen Kam is currently the Chairman and Chief Executive Officer of Golden Meditech.
I'm Glad there not! KABOOM
China Cord Blood Corporation Files its Annual Report on Form 20-F
China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company has filed with the U.S. Securities and Exchange Commission its Annual Report on Form 20-F, which included audited financial statements for the fiscal year ended March 31, 2012. The Form 20-F can be accessed by visiting the U.S. Securities and Exchange Commission's website at http://www.sec.gov and also be found at the Investor Relations Section of CCBC's website at http://ir.chinacordbloodcorp.com. CCBC will provide a hard copy of the Annual Report, including a complete set of audited financial statements, free of charge to its shareholders upon request.
Thanks CO for the HUGE returns! Being Patient pays off BIGTIME!MBD
This Amendment No. 3 ( “Amendment”) relates to the ordinary shares, par value $0.0001 (the “Ordinary Shares”), of China Cord Blood Corporation, a Cayman Islands corporation (the “Issuer” or “CCBC”). This Amendment is being filed jointly by Golden Meditech Stem Cells (BVI) Company Limited, a British Virgin Islands company (“GM Stem Cells”), and Golden Meditech Holdings Limited, a Cayman Islands company (“Golden Meditech” and, collectively with GM Stem Cells, the “Reporting Persons”).
They are entirely different companies. Totally unrelated.
In Reply to 'dcwisc'
locks are china cord blood and cbai one in the same
locks are china cord blood and cbai one in the same
Heading back to $4, I think it could break in low 4's
~ Monday! $CO ~ Earnings posted, pending or coming soon! In Charts and Links Below!
~ $CO ~ Earnings expected on Monday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.
http://stockcharts.com/h-sc/ui?s=CO&p=D&b=3&g=0&id=p88783918276&a=237480049
http://stockcharts.com/h-sc/ui?s=CO&p=W&b=3&g=0&id=p54550695994
~ Google Finance: http://www.google.com/finance?q=CO
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=CO#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=CO+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=CO
Finviz: http://finviz.com/quote.ashx?t=CO
~ BusyStock: http://busystock.com/i.php?s=CO&v=2
<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=CO >>>>>>
http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916
*If the earnings date is in error please ignore error. I do my best.
On December 19, 2011, China Cord Blood Corporation (the “Company”) issued a press release announcing the results of its 2011 Annual General Meeting, which was held on December 19, 2011, in Hong Kong. At the Annual General Meeting, shareholders: (1) elected Ms. Ting Zheng and Dr. Yungang (Ken) Lu to serve on the Board of Directors until the 2014 annual general meeting of the Company or until their respective successors are duly appointed and qualified; and (2) ratified the appointment of KPMG as auditor of the Company for the financial year ending March 31, 2012, and authorized the directors to set the remuneration of the auditors. A copy of the press release is attached hereto as exhibit 99.1.
China Cord Blood Corporation Announces Results of 2011 Annual General Meeting
Share With Friends
0 0Care20 0Stumbleup0Digg0ShareThisNew
HONG KONG, Dec. 19, 2011 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), the first and largest umbilical cord blood banking operator in China, today announced the results of its 2011 Annual General Meeting, which was held on December 19, 2011, in Hong Kong.
At the Annual General Meeting, shareholders
-- Elected Ms. Ting Zheng and Dr. Yungang (Ken) Lu to serve on the Board of
Directors until the 2014 Annual General Meeting of the Company or until
their respective successors are duly appointed and qualified; and
-- Ratified the appointment of KPMG as the independent auditor of the
Company for the financial year ending March 31, 2012, and authorized the
directors to fix the remuneration of the auditors.
About China Cord Blood Corporation
China Cord Blood Corporation is the first and largest umbilical cord blood banking operator in China in terms of geographical coverage and is the only cord blood banking operator with multiple licenses. Under current PRC government regulations, only one licensed cord blood banking operator is permitted to operate in each licensed region and only seven licenses have been authorized as of today. China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services. For more information, please visit our website at http://www.chinacordbloodcorp.com.
For more information, please contact:
China Cord Blood Corporation
Ms. Joeling Law
Tel: (+852) 3605-8180
Email: ir@chinacordbloodcorp.com
ICR, Inc.
In New York: Ashley M. Ammon: 1-646-277-1227
In Beijing: Wen Lei Zheng: +86-10-6583-7510
SOURCE China Cord Blood Corporation
China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2012 Financial Results on Monday, November 28, 2011, after market close in the US.
Nov 18, 2011 05:00:00 (ET)
HONG KONG, Nov. 18, 2011 /PRNewswire via COMTEX/ -- China Cord Blood Corporation (CO, Trade ) ("the Company") today announced its plan to release financial results for the second quarter and first half of fiscal year 2012 on Monday, November 28, 2011, after market close in the US.
The Company will host a conference call at 8:00 a.m. ET on Tuesday, November 29, 2011 to discuss its financial performance and give a brief overview of the Company's recent developments, followed by a question and answer session. Interested parties may access the audio webcast through the Company's IR website at http://ir.chinacordbloodcorp.com . A replay of the webcast will be accessible two hours after the presentation and available for three weeks at the same URL link above. Listeners may also access the call by dialing 1-718-354-1231 or 1-866-519-4004 for US callers or +852-2475-0994 for Hong Kong callers, access code: 20456843.
Please dial in ten minutes prior to the conference call to ensure proper connection, and be prepared to provide your name and company to the operator.
Supplemental financial information referenced in the conference call and the second quarter fiscal 2012 earnings press release will be available at http://www.chinacordbloodcorp.com , in the section titled Investor Center/Press Release, after 4:00 p.m. ET on Monday, November 28, 2011.
Moving strong today. WTH?!?!
OK - there are 7 licenses issued in PRC to operate cord blood banks.
China Cord Blood Corp has 2
Shanghai Stem Cell Technology Co., Ltd has 1.
Beijing China Cord Blood Bank has 1
Who are the other 3 licenses issues to?
The chart has indicated a downward trend since mid September or so. Doesn't look like it will turn up anytime soon, based on 50 and 200 MA (not always true, but better than a coin toss). Best to wait for upward MOMO, IMO.
I also thought it was suppose to have good numbers, and it's basically dropped since it iopened at $5. I've been watching it drop for a while now, thinking about getting in. However, todays dip seemed unusually aggresive. I'm just concerned there's something insider's know that I don't... and it ain't good.
No way for me to justify such a statement other than the movement in the PPS. Watching from the side lines.
Thanks for the reply.
I don't. Q2 earnings are expected to be announced on November 28, 2011. They filed a 6-K yesterday, but nothing I can see as related.
The 50 and 200 day MA looks to be moving apart - not good for chart readers. Points to a downward trend.
China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 19, 2011
Oct 14, 2011 07:00:00 (ET)
HONG KONG, Oct. 14, 2011 /PRNewswire via COMTEX/ -- China Cord Blood Corporation (CO, Trade ) ("CCBC" or "the Company"), the first and largest cord blood banking operator in China, today announced that the Company will hold its annual general meeting of shareholders at its Hong Kong office at 48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong, at 9:00 p.m. Hong Kong Time on December 19, 2011 (8:00 a.m. U.S. Eastern Time on December 19)(8:2011).
Shareholders of record as of November 9, 2011 will be entitled to receive notice of and vote at the annual general meeting. China Cord Blood Corporation filed its annual report on Form 20-F, including its audited financial statements for the fiscal year ended March 31, 2011, with the U.S. Securities and Exchange Commission (the "SEC") on September 28, 2011. CCBC's annual report on Form 20-F can be accessed at the Investor Center section of the Company's website at http://www.chinacordbloodcorp.com , as well as on the SEC's website at http://www.sec.gov . Shareholders may request a meeting notice, proxy statement and hard copy of the annual report on Form 20-F free of charge by contacting ir@chinacordbloodcorp.com.
China Cord Blood Corporation Files Its Annual Report on Form 20-F
http://ih.advfn.com/p.php?pid=nmona&article=49342453&symbol=CO
China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company has filed with the U.S. Securities and Exchange Commission its Annual Report on Form 20-F, which included audited financial statements for the fiscal year ended March 31, 2011. The Form 20-F can be accessed by visiting the U.S. Securities and Exchange Commission's website at www.sec.gov and can also be found at the Investor Relations Section of CCBC's website at http://ir.chinacordbloodcorp.com. CCBC will provide a hard copy of the Annual Report, including a complete set of audited financial statements, free of charge to its shareholders upon request.
About China Cord Blood Corporation
China Cord Blood Corporation is the first and largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood banking operator with multiple licenses. Under current PRC government regulations, only one licensed cord blood banking operator is permitted to operate in each licensed region and only seven licenses have been authorized as of today. China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services. For more information, please visit our website at http://www.chinacordbloodcorp.com.
Safe Harbor Statement
This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events, performance and results of operations, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in statements filed from time to time with the U.S. Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
For more information, please contact:
China Cord Blood Corporation
Ms. Joeling Law
Tel: (+852) 3605-8180
Email: ir@chinacordbloodcorp.com
ICR, Inc.
In New York: Ashley Ammon De Simone: 1-646-277-1227
In Beijing: Wen Lei Zheng: +86-10-6583-7510
SOURCE China Cord Blood Corporation
Followers
|
4
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
431
|
Created
|
09/04/09
|
Type
|
Free
|
Moderators |
CHINA CORD BLOOD CORPORATION (NYSE: CO)
http://www.chinacordbloodcorp.com
Company Information:
CIK 0001467808
CHINA CORD BLOOD CORPORATION, a leading provider of cord blood banking services in China. Expectant parents pay us to process and store the cord blood of their children at birth for potential future use in medical treatment of the children or their family members. The payment structure of our contracts with subscribers enable us to enjoy a steady stream of long term cash inflows from annual storage fees. We enter into 18-year-contracts with our subscribers and charge an initial processing fee at birth and a storage fee each year. These contracts can be terminated early by the parents or further extended, at the option of the children, after the children reach adulthood. We expect annual storage fees to contribute an increasing proportion of our revenue as the number of our subscribers accumulated over the years continues to grow. In addition to our fee-based commercial services, we also preserve cord blood units donated by the public and charge fees for matching units provided for patients in need of transplants. This revenue accounts for a small percentage of our total revenue.
The PRC government authorities have been following a "one license per region" policy, allowing each licensee, including us, to operate within its own region without competition. The application process for a cord blood banking license takes several years, during which time the applicant usually incurs a substantial amount of initial investments, including constructing cord blood bank facilities to demonstrate to the government authorities that it is capable of meeting the stringent application requirements. This licensing process may deter newcomers with fewer resources and less experience from competing for licenses with established cord blood banking operators in China.
Our management team successfully pioneered the commercialization of cord blood banking services in China. Jiachenhong, our Beijing-based subsidiary with operations dating back to 2002, was the operator of the first licensed cord blood bank in China. We have also developed a hospital network consisting of over 90 major hospitals in Beijing to perform cord blood collection services for our subscribers. To expand the geographic coverage of our business, we acquired the right to operate in Guangdong through the acquisition of Nuoya in May 2007. The acquisition enabled us to significantly increase the size of the market that we can address. We believe we will be able to apply the experience we gained in our successful operation in Beijing to our more recently commenced operation in Guangdong. As of June 30, 2009, we had capacity to store approximately 645,000 additional units, and we believe we have the ability to further expand our capacity to meet the increasing market demand.
Currently, we are the sole cord blood banking licensee in Beijing and Guangdong. So far, cord blood banking licenses have been issued for only six of China's 31 regions, with another four licenses expected to be issued by 2010. We expect to continue to grow our business through existing market penetration and geographical expansion. Our existing operations cover an aggregate population of approximately 110 million, including 94 million in Guangdong, which is larger than all but 12 countries in the world. According to the National Bureau of Statistics of China, there were 1.2 million newborns in Beijing and Guangdong in 2007. As the PRC government authorities issue cord blood banking licenses in more regions, we believe that there will be significant growth opportunities in China. China has a population of approximately 1.3 billion. According to the National Bureau of Statistics of China, there were 15.9 million newborns in China in 2007, representing approximately 12.0% of newborns worldwide. In addition to the large number of newborns in China, we expect increased demand for our services to be driven by a number of factors, including increasing disposable income in urban areas; greater attention to health issues as people become more financially secure; emphasis on children under China's one-child policy; and heightened public awareness of the benefits associated with cord blood storage.
Principal activities
China Cord Blood Services Corporation (the "Company") and its subsidiaries (collectively the "Group") are principally engaged in the provision of umbilical cord blood storage and ancillary services in its cord blood banks in the People's Republic of China ("PRC"). As of March 31, 2009, the Group operates two cord blood banks in the Beijing municipality and Guangdong Province, the PRC.
The Group provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. The Group also tests, processes and stores donated cord blood, and provides matching services to the public for a fee.
The operation of cord blood banks in the PRC is regulated by certain laws and regulations. Cord blood bank operators in the PRC are required to possess a Blood Station Operation License. The licensing process for a cord blood bank is stringent and lengthy. The Ministry of Health of the PRC and the local Departments of Health have granted Blood Station Operation Licenses to cord blood banks that provide cord blood banking services. Cord blood banks collecting cord blood units from donors and providing matching cord blood units to the public without a duly obtained Blood Station Operation License face the risk of being shut down by the government. Only six cord blood banking licenses have been issued by the authorities as of March 31, 2009, of which the Company holds two. Due to the lack of a consistent and well-developed regulatory framework, operation in the cord blood banking industry in the PRC involves significant ambiguities, uncertainties and risks. The industry is highly regulated and any unilateral changes in regulations by the authorities may have a significant adverse impact on the Group's results of operations.
SEC Filings:
-------------------
Considerations:
Insider Buys:
SEC Transaction Summary - Last 6 Months - last checked April 17, 2010
Latest News:
http://finance.yahoo.com/q/h?s=CO+Headlines
List of Subsidiaries:
Exhibit 21.1 from F-1/A filed 11.18.09
http://www.sec.gov/Archives/edgar/data/1467808/000114420409052921/v161765_ex21-1.htm
China Cord Blood Services Corporation | Cayman Islands |
China Stem Cells Holdings Limited | Cayman Islands |
Beijing Jiachenhong Biological Technologies Co., Limited | PR China |
China Stem Cells (South) Company Limited | British Virgin Islands |
Guangzhou Municipality Tianhe Nuoya Bio-engineering Co. Ltd. | China |
China Stem Cells (East) Company Limited | British Virgin Islands |
19 November 2009 China Cord Blood Corp. NYSE Euronext Opening Bell
http://www.youtube.com/watch?v=OesNVlIo6xg
Transfer Agent:
Continental Stock Transfer & Trust Company
17 Battery Place, 8th Floor
New York 10004
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock. Being a moderator isn't a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |